Gursky S, Olopade O I, Rowley J D
Department of Biochemistry and Molecular Biology, 5841 South Maryland Avenue, MC 2115, The University of Chicago, Chicago, IL 60637, USA.
Cancer Genet Cytogenet. 2001 Sep;129(2):93-101. doi: 10.1016/s0165-4608(01)00444-7.
Chromosome band 9p21 is a frequent target of homozygous deletion in many tumor types. Putative tumor suppressor genes, CDKN2A (p16), p14(ARF) and CDKN2B (p15), were localized to 9p21. However, there have been reports that suggest that there may be other genes targeted for inactivation in the region. We have developed a method to search for transcribed sequences within large genomic regions. We tested our approach in a 100-kilobase region on 9p21, which is 40 kilobases telomeric to CDKN2A. The method, termed expressed sequence selection (ESS), resulted in the isolation of genomic fragments known to be from 9q21 that are homologous to transcribed sequences. One fragment was used to obtain a 1.2 kilobase cDNA. The sequence of the 5' half of the cDNA was almost identical to exons 3-5 of the MTAP gene, which maps to chromosome band 9p21. The 3' portion of the cDNA had sequence homology to the ALA gene, which maps to chromosome arm 9q. Using Northern blot analysis, the 1.2 Kb cDNA identified several widely expressed transcripts ranging from 1 Kb to 8.5 Kb and displayed a complex pattern of alternative splicing in which certain exons of the 1.2 Kb cDNA are excluded from some of the splice products. Using cancer tissue Northern blots, we could show that all of the transcripts are absent from a leukemia cell line and a lung cancer cell line (K562, A549) with homozygous, genomic deletions within chromosome band 9p21. In addition, the 7 Kb transcript is also absent from two additional tumor cell lines (Molt4, a leukemia derived cell line, and in G361, a melanoma derived cell line) with homozygous deletions. Further investigation will determine whether the difference in the expression pattern between the 7 Kb transcript compared with the other sized transcripts could be due to specific targeting for alteration in certain tumor types.
染色体带9p21是许多肿瘤类型中纯合缺失的常见靶点。推定的肿瘤抑制基因CDKN2A(p16)、p14(ARF)和CDKN2B(p15)定位于9p21。然而,有报道表明该区域可能还有其他基因成为失活靶点。我们开发了一种在大基因组区域内搜索转录序列的方法。我们在9p21上一个100千碱基的区域测试了我们的方法,该区域位于CDKN2A端粒方向40千碱基处。该方法称为表达序列筛选(ESS),结果分离出了已知来自9q21且与转录序列同源的基因组片段。其中一个片段用于获得一个1.2千碱基的cDNA。该cDNA 5'端一半的序列与定位于染色体带9p21的MTAP基因的外显子3 - 5几乎相同。该cDNA的3'部分与定位于染色体臂9q的ALA基因有序列同源性。使用Northern印迹分析,该1.2千碱基的cDNA鉴定出了几种广泛表达的转录本,大小从1千碱基到8.5千碱基不等,并显示出复杂的可变剪接模式,其中1.2千碱基cDNA的某些外显子在一些剪接产物中被排除。使用癌组织Northern印迹,我们可以表明,在染色体带9p21内有纯合基因组缺失的白血病细胞系和肺癌细胞系(K562、A549)中所有这些转录本均不存在。此外,在另外两个有纯合缺失的肿瘤细胞系(白血病衍生细胞系Molt4和黑色素瘤衍生细胞系G361)中,7千碱基的转录本也不存在。进一步的研究将确定7千碱基转录本与其他大小转录本之间表达模式的差异是否可能是由于某些肿瘤类型中特定的改变靶点所致。